Carflexin Flavoured 20mg Tablets
国家: 澳大利亚
语言: 英文
来源: APVMA (Australian Pesticides and Veterinary Medicines Authority)
资料单张 有效成分:
CARPROFEN
可用日期:
DECHRA VETERINARY PRODUCTS (AUSTRALIA) PTY. LTD.
INN（国际名称）:
carprofen(20mg/Tb)
药物剂型:
ORAL TABLET
组成:
CARPROFEN ANTI-INFLAMMATORY-NONSTEROIDAL Active 20.0 mg/Tb
每包单位数:
100 Tabs
类:
VM - Veterinary Medicine
厂商:
APEX LABORATORIES
治疗组:
DOG | BITCH | CASTRATE | PUPPY
治疗领域:
MUSCULOSKELETAL SYSTEM
疗效迹象:
ANALGESIC | ANTI-INFLAMMATORY AGENT | ANTIPYRETIC | BONE SORENESS | BRUISING | BURSITIS | COLIC | INFLAMMATORY RHEUMATIC ARTHRIT | JOINT DISEASE | LIGAMENT SPRAINS | MUSCLE RELAXANT | MUSCLE SORENESS | OSTEOARTHRITIS | PLATELET ACTIVITY | RHEUMATISM | SEDATIVE | SPASMOLYTIC | SPRAINS | STRAINS | TENDON SPRAINS | TRAUMATIC SWELLING
產品總結:
Poison schedule: 4; Withholding period: WHP: N/A; Host/pest details: DOG: [ANALGESIC, ANTI-INFLAMMATORY AGENT]; A non-steroidal anti-inflammatory agent used in the treatment of inflammation and to provide analgesia in dogs.Should not be used in dogs exhibiting hypersensitivity to carprofen. See PRECAUTIONS on label also.
授权状态:
Registered
授权日期:
2023-07-01
资料单张
APEX CARPROFEN 20MG TABLETS WITH BEEF FLAVOURING
63924/134515
Product Name:
APVMA Approval No:
Label Name:
APEX CARPROFEN 20MG TABLETS WITH BEEF FLAVOURING
Signal Headings:
PRESCRIPTION ANIMAL REMEDY
KEEP OUT OF REACH OF CHILDREN
FOR ANIMAL TREATMENT ONLY
Constituent
Statements:
20 mg/Tb CARPROFEN
Claims:
Carprofen is a non steroidal anti-inflammatory agent used in the
treatment of inflammation
and to provide analgesia in dogs.
Net Contents:
100 Tabs
Directions for Use:
Restraints:
Contraindications:
Apex Carprofen Tablets should not be used in dogs exhibiting previous
hypersensitivity to
carprofen. The elimination time of NSAIDs, including carprofen, in the
cat is longer than in
the dog, and the therapeutic index is lower. In the absence of
specific data, the use of Apex
Carprofen Tablets in the cat is contraindicated.
Precautions:
As a class, cyclooxygenase inhibitory NSAIDs may be associated with
gastrointestinal and
renal toxicity.
Effects may result from decreased prostaglandin production and
inhibition of the enzyme
cyclooxygenase, which is responsible for the formation of
prostaglandins from arachidonic
acid. When NSAIDs inhibit prostaglandins that cause inflammation they
may also inhibit
those prostaglandins which maintain homeostatic function. These
anti-prostaglandin effects
may result in clinically significant disease in patients with
underlying or pre-existing disease
more often than in healthy patients.
Sensitivity to drug-associated adverse effects varies with the
individual patient. All dogs
should undergo a thorough clinical examination and appropriate
laboratory tests before RLP APPROVED
introduction of NSAID therapy. Appropriate laboratory tests and
periodic re-examination
administration should be considered.
NSAID therapy could unmask disease, which has previously been
undiagnosed due to the
absence of clinical signs. Therefore use with caution in dogs that are
less than 6 weeks of
age, debilitated or aged, have existing cardiac, hepatic or renal
disease, or are dehydrated,
hypovolaemic or hypo
阅读完整的文件
产品特点
Apex Carprofen 20mg, 50mg and 100mg Tablets
Page 1 of 5
-----------------------------------------------------------------------------------------------------------------------------------------------------------
MATERIAL SAFETY DATA SHEET
APEX CARPROFEN 20MG, 50MG AND 100MG TABLETS
AND APEX CARPROFEN 20MG, 50MG AND 100 MG
TABLETS WITH BEEF FLAVOURING
CLASSIFIED AS HAZARDOUS ACCORDING TO THE CRITERIA OF NOHSC
SECTION I
IDENTIFICATION OF THE MATERIAL AND SUPPLIER
Product Name
Apex Carprofen Tablets
Recommended Use
To treat musculoskeletal disorders and other conditions where
NSAIDs are indicated.
Supplier details
Apex Laboratories Pty Ltd
ACN
000
397
240
61
Chivers
Road
Somersby
NSW
2250
+61 2 4372 1661 (Business hours – 8.30am – 5.30pm)
+61 2 4372 1668 (fax)
www.apexlabs.com.au
Emergency contact
As above or Poisons Information Centre 131126 (Australia)
SECTION II
HAZARD IDENTIFICATION
Classification
Classified as hazardous according to the criteria of NOHSC
Risk Phrases
R42/43 May cause sensitisation by inhalation and skin contact
Safety Phrases
None allocated
ADG Class
None allocated
Hazchem Code
None allocated
Poisons Schedule
S4
SECTION III
COMPOSITION
Ingredients
CAS No
Proportion
TWA
mg/m
3
STEL
mg/m
3
Carprofen
10-<30% not
set
not
set
Other non hazardous ingredients
to 100%
The TWA exposure value is the average airborne concentration of
a particular substance when calculated over a
normal 8 hour working day for a 5 day working week over an
entire working lifetime. The TWA exposure standard
set by Worksafe Australia for dusts not otherwise specified is
10mg/m
3
. The STEL (Short Term Exposure Limit) is an
exposure value that should not be exceeded for more than 15 minutes
and should not be repeated for more than 4
tim
阅读完整的文件
